Hubei Guangji Pharmaceutical Co Ltd (000952) — Cash Flow Quality Index
Hubei Guangji Pharmaceutical Co Ltd (000952) has a Cash Flow Quality Index of -4.76x as of June 2023. Operating cash flow of CN¥-86.71 Million is below net income of CN¥18.23 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Hubei Guangji Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hubei Guangji Pharmaceutical Co Ltd Cash Flow Quality Index (1998–2022)
Historical Cash Flow Quality Index for Hubei Guangji Pharmaceutical Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Hubei Guangji Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hubei Guangji Pharmaceutical Co Ltd (1998–2022)
Year-by-year earnings quality comparison for Hubei Guangji Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 000952 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.94x | CN¥45.08 Million | CN¥47.72 Million | ▲ +31.7% |
| 2021 | 0.72x | CN¥75.91 Million | CN¥105.81 Million | ▼ -57.8% |
| 2020 | 1.70x | CN¥119.38 Million | CN¥70.30 Million | ▼ -2.0% |
| 2019 | 1.73x | CN¥144.20 Million | CN¥83.18 Million | ▲ +29.9% |
| 2018 | 1.33x | CN¥231.44 Million | CN¥173.41 Million | ▼ -20.8% |
| 2017 | 1.69x | CN¥178.83 Million | CN¥106.06 Million | ▲ +46.7% |
| 2016 | 1.15x | CN¥167.07 Million | CN¥145.32 Million | ▲ +163.5% |
| 2015 | -1.81x | CN¥-33.35 Million | CN¥18.42 Million | ▼ -101.8% |
| 2011 | 102.56x | CN¥81.88 Million | CN¥798.36K | ▲ +1155.0% |
| 2010 | 8.17x | CN¥77.18 Million | CN¥9.44 Million | ▲ +1348.5% |
| 2009 | -0.65x | CN¥-24.35 Million | CN¥37.20 Million | ▼ -128.9% |
| 2008 | 2.27x | CN¥220.70 Million | CN¥97.35 Million | ▲ +33.6% |
| 2007 | 1.70x | CN¥331.98 Million | CN¥195.56 Million | ▼ -78.9% |
| 2006 | 8.04x | CN¥125.95 Million | CN¥15.66 Million | ▲ +27.3% |
| 2005 | 6.32x | CN¥54.14 Million | CN¥8.57 Million | ▲ +1651.2% |
| 2004 | -0.41x | CN¥-3.32 Million | CN¥8.14 Million | ▲ +79.6% |
| 2003 | -2.00x | CN¥-15.40 Million | CN¥7.70 Million | ▼ -152.1% |
| 2002 | 3.84x | CN¥76.20 Million | CN¥19.87 Million | ▲ +521.0% |
| 2001 | -0.91x | CN¥-22.40 Million | CN¥24.59 Million | ▼ -157.4% |
| 2000 | 1.59x | CN¥48.57 Million | CN¥30.62 Million | ▼ -27.3% |
| 1999 | 2.18x | CN¥68.57 Million | CN¥31.42 Million | ▲ +467.5% |
| 1998 | -0.59x | CN¥-15.29 Million | CN¥25.75 Million | — |